Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human androgen receptor: structure/function relationship in normal and pathological situations.

A O Brinkmann1, G Jenster, G G Kuiper

  • 1Department of Endocrinology and Reproduction, Erasmus University, Rotterdam, The Netherlands.

The Journal of Steroid Biochemistry and Molecular Biology
|March 1, 1992
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer-ID: Toward Identification of Cancer by Tumor-Derived Extracellular Vesicles in Blood.

Frontiers in oncology·2020
Same author

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression.

British journal of cancer·2015
Same author

Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects.

Advances in experimental medicine and biology·2015
Same author

The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.

British journal of cancer·2014
Same author

Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer.

Oncogene·2014
Same author

Variable loss of functional activities of androgen receptor mutants in patients with androgen insensitivity syndrome.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation·2013

The human androgen receptor (hAR) has distinct functional regions. Mutations in the hAR gene cause androgen insensitivity syndrome (AIS) in 46, XY individuals, leading to inactive receptors and significant health impacts.

Area of Science:

  • Molecular Endocrinology
  • Genetics
  • Cell Biology

Background:

  • The human androgen receptor (hAR) plays a crucial role in male sexual development and function.
  • Understanding the structure-function relationship of hAR is vital for diagnosing and treating androgen-related disorders.
  • hAR exhibits heterogeneity in prostate cancer cells and is implicated in androgen insensitivity syndrome (AIS).

Purpose of the Study:

  • To delineate the functional domains of the human androgen receptor (hAR).
  • To investigate the structural basis of hAR dysfunction in prostate cancer cells and AIS.
  • To identify specific mutations in the hAR gene associated with impaired receptor activity.

Main Methods:

  • Expression of hAR deletion mutants in COS and HeLa cells.

Related Experiment Videos

  • Metabolic labeling with radioactive orthophosphate to study hAR phosphorylation.
  • Structural analysis of the AR gene in LNCaP cells and individuals with AIS.
  • Main Results:

    • Distinct domains of hAR were identified for hormone binding, DNA binding, transactivation, and nuclear translocation.
    • hAR in LNCaP cells is a heterogeneous phosphoprotein, existing as 110 kDa and 112 kDa forms.
    • Mutations in LNCaP cells and individuals with AIS lead to altered binding specificity, transactivation, and functionally inactive AR proteins.

    Conclusions:

    • The hAR is a heterogeneous phosphoprotein with distinct functional domains.
    • Point mutations in the hAR gene can cause functionally inactive receptors, leading to AIS in 46, XY individuals.
    • hAR dysfunction significantly impacts phenotype and fertility in affected individuals.